Did you find what you are/were looking for
?
If not, read below and browse through other relevant pages for similar market research
reports OR get in touch with us through the form/contact info in your right navigation
panel and we’ll share relevant market report titles for you to explore.
- Type II Diabetes Therapeutics - Global Drug Forecasts and Treatment Analysis to 2020
Report SummaryGlobalData, the industry analysis specialist, has released its new report, Type II Diabetes - Global Drug Forecasts and Treatment Analysis to 2020”. The report is an essential source of infor...
- Epidemiology: Type 2 Diabetes – Rising obesity and aging populations are driving diabetes trends
Report SummaryDespite advancements in medical technology, diabetes prevalence is on the increase, driven by rises in obesity. Across the seven major markets, population aging also accounts for a large proportion of di...
- Avandia (Type 2 Diabetes) – Analysis and Forecasts to 2020
Report SummaryGlobalData’s pharmaceuticals report, Avandia (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Avandia sales estimates for US and EU5. In addition, it covers detailed clinic...
- ASP1941 (Type 2 Diabetes) – Analysis and Forecasts to 2020
Report SummaryGlobalData’s pharmaceuticals report, ASP1941 (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides ASP1941 sales estimates for US, EU5 and Japan. In addition, it covers detailed...
- Apidra (Type 2 Diabetes) – Analysis and Forecasts to 2020
Report SummaryGlobalData’s pharmaceuticals report, Apidra (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Apidra sales estimates for US, EU5 and Japan. In addition, it covers detailed c...
- Amaryl (Type 2 Diabetes) – Analysis and Forecasts to 2020
Report SummaryGlobalData’s pharmaceuticals report, Amaryl (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Amaryl sales estimates for US, EU-5 and Japan. In addition, it covers detailed ...
- Aleglitazar (Type 2 Diabetes) – Analysis and Forecasts to 2020
Report SummaryGlobalData’s pharmaceuticals report, Aleglitazar (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Aleglitazar sales estimates for US and EU5. In addition, it covers detaile...
- Actos (Type 2 Diabetes) – Analysis and Forecasts to 2020
Report SummaryGlobalData’s pharmaceuticals report, Actos (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Actos sales estimates for US, EU5 and Japan. In addition, it covers detailed cli...
- Treatment Algorithms: Type 2 Diabetes – Novel classes drive fragmentation of treatment choices in type 2 diabetes
IntroductionDatamonitor surveyed 199 primary care physicians and specialists across the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK) on their type 2 diabetes treatment choices and prescribing behavio... - Epidemiology: Diabetes in India - a country faced with a mammoth diabetes epidemic
IntroductionThe World Health Organization (WHO) estimates that worldwide, there are currently 220 million people living with diabetes. Diabetes is becoming an important chronic disease in India. In 2010, 45.5 million i...